Pharmaceutical group · Ireland
Perrigo
A group of 17 companies with 151 medicines in 3 countries.
Group structure
17 companies in 6 countries
Loading…
Pharmaceutical group · Ireland
A group of 17 companies with 151 medicines in 3 countries.
17 companies in 6 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 151
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACETAMINOPHEN650mg · Tablet, extended release | Paracetamol | United States | Marketed | 2000 |
| ACETAMINOPHEN ARTHRITIS PAIN650 mg · Tablet (Extended-Release) | Paracetamol | Canada | Marketed | 2006 |
| ALLERGY FORMULA CAPLETS25 mg · Tablet | Diphenhydramine | Canada | Marketed | 1997 |
| ANTITUSSIVE12.5mg/5ml · Syrup | Diphenhydramine | United States | Not marketed | |
| BRONCHOGRIP POLVO PARA SOLUCION ORAL500 mg + 200 mg + 10 mg · Polvo para solución oral | Paracetamol, Guaifenesin, Phenylephrine | Spain | Marketed | 2019 |
| CAP-PROFEN200mg · Tablet | Ibuprofen | United States | Not marketed | 1987 |
| CETIRIZINE HYDROCHLORIDE ALLERGY10mg · Tablet, orally disintegrating | Cetirizine | United States | Marketed | 2015 |
| CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY5mg/5ml · Solution | Cetirizine | United States | Marketed | 2008 |
| CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF5mg/5ml · Solution | Cetirizine | United States | Marketed | 2008 |
| CHILDREN'S IBUPROFEN100mg/5ml · Suspension | Ibuprofen | United States | Marketed | 1998 |
| CHILDREN'S IBUPROFEN SUSPENSION100 mg / 5 ml · Suspension | Ibuprofen | Canada | Marketed | 2007 |
| CLEARLAX100 % · Powder For Solution | Macrogol | Canada | Marketed | 2010 |
| CLINDETS1% base · Swab | Clindamycin | United States | Not marketed | 1996 |
| DUAL ACTION PAIN250 mg + 125 mg · Tablet | Paracetamol, Ibuprofen | Canada | Authorised | |
| FAMOTIDINE10mg · Tablet, chewable | Famotidine | United States | Not marketed | 2003 |
| FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE800mg; 10mg; 165mg · Tablet, chewable | Carbonate, Famotidine, Hydroxide | United States | Marketed | 2008 |
| FENIVIR 10 mg/g CREMA1 g · Crema | Penciclovir | Spain | Marketed | 1997 |
| HEMORRHOIDAL OINTMENT14.05 % / w/w + 74.9 % / w/w + 0.25 % / w/w · Ointment | Mineral oil, Petrolatum, Phenylephrine | Canada | Marketed | 2022 |
| HYDROCORTISONE0.5% | 1% | 2.5% · Lotion | Hydrocortisone | United States | Not marketed | 1978 |
| IBUPROFEN100mg | 50mg · Tablet, chewable | Ibuprofen | United States | Marketed | 2004 |
| IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE200mg; 10mg · Tablet | Ibuprofen, Phenylephrine | United States | Marketed | 2014 |
| IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE100mg/5ml; 15mg/5ml · Suspension | Ibuprofen, Pseudoephedrine | United States | Not marketed | 2003 |
| IBUPROFEN SODIUM200mg base · Tablet | Ibuprofen | United States | Not marketed | 2015 |
| JUNIOR STRENGTH IBUPROFEN100mg · Tablet | Ibuprofen | United States | Not marketed | 1999 |
| KETOPROFEN12.5mg · Tablet | Ketoprofen | United States | Not marketed | 2002 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 96 | 7 | 89 | CompaniesAll medicines |
| United States | 37 | 35 | 2 | CompaniesAll medicines |
| Spain | 18 | 12 | 6 | CompaniesAll medicines |
Also in the registers of Australia, Colombia, Croatia, France, Italy, Sweden
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
ASIC,ASIC - Company Dataset,declared13October2026 extract,CC BY3.0 Australia,https://data.gov.au/data/dataset/asic-companies. Normalized and independently classified by Prognia;no endorsement.
Licence: Creative Commons Attribution 3.0 Australia
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Läkemedelsverket, Sweden, Förvaringstemperatur och hållbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
Keep Perrigo’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.